Cision PR Newswire

AccidentAccidentAir PollutionAll NewsAnnoucementArgricultureArtASEANBook

Ascletis’ Oral Small Molecule GLP-1, ASC30, Demonstrated Placebo-Adjusted HbA1c Reduction of 1.7% at 12 Weeks from Its U.S. Phase II Study in Participants with...

- ASC30 reduced HbA1c by a placebo-adjusted 1.7%, 1.6% and 1.7% from baseline for 40 mg, 60 mg and 80 mg, respectively, at 12 weeks, the...
1...4,2364,2374,238...4,481Page 4,237 of 4,481